Connect with us
Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...
Europacific Growth Fund, legal owner of Grifols shares, lent over 100 million euros worth of shares, reducing its ownership from 3.4% to 3.2%. Capital Research and...
MDMA became famous in the 80s as a party drug under the names Ecstasy or Molly - complete with abuse, damage, and deaths. As a result,...
AstraZeneca Spain's president, Rick R. Suárez, announced a €1.3 billion investment in Catalonia until 2027, exceeding previous plans by €500 million. They aim to employ 2,000...
BlackRock, Capital Research and Management Company, and Jefferies Financial Group lend over 170 million euros in Grifols shares. Specifically, BlackRock, which has a 4.3% stake in...
Almirall has acquired exclusive rights to Eloxx Pharmaceuticals' ZKN-013, a potentially promising treatment for rare dermatological diseases. Almirall gains global development and commercialization rights, paying Eloxx...
AstraZeneca and Wivi Vision were awarded the Bioèxit Prize during the Nit event organized by CataloniaBio&HealthTech. AstraZeneca was recognized for establishing its global hub in Barcelona,...
In the Spanish biotech sector, 60% of employees are women, yet only 37% of leadership positions in companies are held by women, according to a report...
Braingaze, a digital cognitive health spin-off of the University of Barcelona, successfully closed an investment round, raising €1.5 million. Led by Ryse Asset Management, the funds...
The main European stock markets opened this Wednesday with mixed trends. Specifically, Paris and London lost 0.1% and 0.05%, respectively, while Milan and Frankfurt rose 0.16%...
 |
|
 |  |
 |
|